14,084 Shares in Fresenius Medical Care AG & Co. (FMS) Acquired by Lester Murray Antman dba SimplyRich

Lester Murray Antman dba SimplyRich purchased a new position in shares of Fresenius Medical Care AG & Co. (NYSE:FMS) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 14,084 shares of the company’s stock, valued at approximately $571,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. We Are One Seven LLC acquired a new position in shares of Fresenius Medical Care AG & Co. during the 4th quarter worth $165,000. LPL Financial LLC grew its stake in Fresenius Medical Care AG & Co. by 38.3% in the 3rd quarter. LPL Financial LLC now owns 6,278 shares of the company’s stock valued at $323,000 after buying an additional 1,739 shares during the last quarter. Two Sigma Investments LP acquired a new position in Fresenius Medical Care AG & Co. in the 4th quarter valued at $7,553,000. FNY Investment Advisers LLC acquired a new position in Fresenius Medical Care AG & Co. in the 4th quarter valued at $583,000. Finally, Stifel Financial Corp grew its stake in Fresenius Medical Care AG & Co. by 49.9% in the 4th quarter. Stifel Financial Corp now owns 20,179 shares of the company’s stock valued at $659,000 after buying an additional 6,720 shares during the last quarter. Institutional investors own 1.88% of the company’s stock.

NYSE FMS traded up $0.55 during midday trading on Friday, hitting $42.75. The company had a trading volume of 415,964 shares, compared to its average volume of 245,187. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.25 and a quick ratio of 1.02. The firm has a market capitalization of $26.24 billion, a price-to-earnings ratio of 18.83, a P/E/G ratio of 2.76 and a beta of 1.40. Fresenius Medical Care AG & Co. has a fifty-two week low of $30.99 and a fifty-two week high of $53.40.

Fresenius Medical Care AG & Co. (NYSE:FMS) last posted its quarterly earnings results on Thursday, May 2nd. The company reported $0.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.52 by $0.07. The company had revenue of $4.13 billion for the quarter, compared to analyst estimates of $4.58 billion. Fresenius Medical Care AG & Co. had a net margin of 12.00% and a return on equity of 10.14%. The business’s quarterly revenue was up 3.9% on a year-over-year basis. During the same period last year, the business posted $0.91 EPS. As a group, sell-side analysts expect that Fresenius Medical Care AG & Co. will post 2.46 earnings per share for the current fiscal year.

FMS has been the topic of a number of research analyst reports. SunTrust Banks raised their target price on shares of Fresenius Medical Care AG & Co. to $48.00 and gave the company a “positive” rating in a research note on Thursday, February 21st. DZ Bank reiterated a “neutral” rating on shares of Fresenius Medical Care AG & Co. in a research note on Tuesday, March 5th. Royal Bank of Canada reiterated a “neutral” rating on shares of Fresenius Medical Care AG & Co. in a research note on Monday, March 18th. Finally, Zacks Investment Research upgraded shares of Fresenius Medical Care AG & Co. from a “sell” rating to a “hold” rating in a research note on Tuesday, February 19th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and four have given a buy rating to the stock. Fresenius Medical Care AG & Co. presently has an average rating of “Hold” and a consensus target price of $65.00.

ILLEGAL ACTIVITY WARNING: “14,084 Shares in Fresenius Medical Care AG & Co. (FMS) Acquired by Lester Murray Antman dba SimplyRich” was published by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark law. The original version of this story can be accessed at https://www.baseballdailydigest.com/news/2019/05/04/14084-shares-in-fresenius-medical-care-ag-co-fms-acquired-by-lester-murray-antman-dba-simplyrich.html.

About Fresenius Medical Care AG & Co.

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Read More: Google Finance Portfolio

Want to see what other hedge funds are holding FMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fresenius Medical Care AG & Co. (NYSE:FMS).

Institutional Ownership by Quarter for Fresenius Medical Care AG & Co. (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care AG & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. and related companies with MarketBeat.com's FREE daily email newsletter.